Apellis Pharmaceuticals (APLS) PT Lowered to $30 at Scotiabank
Tweet Send to a Friend
(Updated - November 6, 2024 7:53 AM EST)
Scotiabank analyst Greg Harrison lowered the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Scotiabank analyst Greg Harrison lowered the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
